![Mondher Mahjoubi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mondher Mahjoubi
Corporate Officer/Principal bei
GSK PLC
Profil
Dr. Mondher Mahjoubi, MD, is a Chief Patient Officer at GSK Plc, a Chairman at PDC Line Pharma SASU, a Member at American Society of Clinical Oncology, Inc. and a Member at European Society for Medical Oncology.
Dr. Mahjoubi was previously employed as a Chairman-Executive Board & Chief Executive Officer by Innate Pharma SA, a Senior VP-Global Product Strategy by AstraZeneca PLC, and a Senior Vice President-Global Product Strategy by Genentech, Inc. He received his graduate degree from the University of Tunis.
Aktive Positionen von Mondher Mahjoubi
| Unternehmen | Position | Beginn |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01.01.2026 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology Develops plasmacytoid dendritic cells loaded with cancer antigens | Vorsitzender | - |
Ehemalige bekannte Positionen von Mondher Mahjoubi
| Unternehmen | Position | Ende |
|---|---|---|
| INNATE PHARMA | Vorstandsvorsitzender | 01.01.2024 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 13.01.2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.01.2013 |
Ausbildung von Mondher Mahjoubi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
University of Tunis
 University of Tunis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology Develops plasmacytoid dendritic cells loaded with cancer antigens | Health Technology |
